Health Catalyst (HCAT) insider sale notice: 4,471 shares via Morgan Stanley

Rhea-AI Filing Summary

Health Catalyst, Inc. sale notice lists 4,471 shares of common stock proposed to be sold through Morgan Stanley Smith Barney LLC.

The filing shows 9,762 shares of restricted stock were sold in the past three months and that shares outstanding were 70,730,884 as of 02/26/2026. The securities are identified as restricted stock issued for compensation.

Insights

Securities Counsel

Routine Form 144 filing for sale of restricted shares; no material company event.

The notice lists 4,471 shares to be sold through Morgan Stanley Smith Barney LLC and identifies the securities as restricted stock issued for compensation. This aligns with an insider or affiliate disposing of previously issued compensation shares.

Timing, proceeds recipient, and sale method details are not provided in the excerpt; subsequent broker reports or Form 4/5 filings may supply execution details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	4471	7814.41	70730884	02/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2026	Restricted Stock	Health Catalyst, Inc.			4471	02/26/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Linda Llewelyn c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/01/2025	9762	28311.75

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for HCAT disclose?

The filing discloses a proposed sale of 4,471 shares of common stock through Morgan Stanley Smith Barney LLC. It also notes the shares are restricted stock issued for compensation.

How many HCAT shares were sold in the past three months?

The document reports 9,762 shares of restricted stock were sold during the past three months. This figure is presented in the filing as recent dispositions by the reporting party.

What is Health Catalyst's shares outstanding figure in the filing?

The filing shows shares outstanding of 70,730,884 as of 02/26/2026. That number is presented in the securities information section of the notice.

Who is the broker handling the proposed sale in the HCAT Form 144?

The prospective sale is listed as handled by Morgan Stanley Smith Barney LLC at 1 New York Plaza, 38th Floor, New York, NY, per the filing's securities section.

Does the Form 144 indicate why the shares were issued?

Yes; the securities are labeled as restricted stock and the transaction is associated with compensation, indicating the shares originated from an equity compensation grant.